Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC in premanifest Huntington's disease
NCT05509153Phase 2Recruiting
- Sponsor
- Western Sydney Local Health District
- Start
- Jun 2024
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in Huntington disease (HD), sponsored by Western Sydney Local Health District. Started Jun 2024; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on NCT05509153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05509153.